The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced that, for the first time, the U.S. Food and Drug Administration (FDA) has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus (EBOV) infections. This agreement was made possible […]Continue Reading ...
A six-month-old baby in the eastern DR Congo city of Bunia has died of Ebola, becoming the first fatality of the disease in a provincial capital, the heath ministry said Thursday. Bunia, which has a population of 300,000, is the capital of Ituri province, which along with neighbouring North Kivu province has been battling an […]Continue Reading ...
Bunia is the second largest city in the Democratic Republic of Congo (DRC). This week (20th of March 2019), the Health Ministry confirmed a case of the highly fatal Ebola virus infection at Bunia. Bunia has a population of nearly one million and this announcement has sparked fear. 3d illustration of a cross-section of an […]Continue Reading ...
The Lancet has reported about the alarming status of Ebola in the Democratic Republic of Congo (DRC) on the 4th of this month following a reported 785 deaths due to the disease in the country. Ebola Virus illustration. Image Credit: Festa / Shutterstock The DRC has reported 22 new cases to add to the outbreak. […]Continue Reading ...
“It’s an incomplete study, a work in progress,” said Simon J. Anthony, a virologist at Columbia University.Continue Reading ...
AHF urges the United Nations to follow its existing mandate for the Democratic Republic of the Congo to ensure Ebola-relief efforts can proceed without the threat of violence against healthcare workers, resources and civilians. As the second worst Ebola outbreak in history rages on in Central Sub-Saharan Africa, AIDS Healthcare Foundation (AHF) urges the United […]Continue Reading ...
Scientists from academia, industry, and government have developed a combination of monoclonal antibodies (mAbs) that protected animals from all three Ebola viruses known to cause human disease. Their work is described in two companion studies published online in the journal Cell Host & Microbe. The mAb “cocktail,” called MBP134, is the first experimental treatment to […]Continue Reading ...
NEIDL researcher Robert Davey has found that derivatives from a commonly used anti-malarial can prevent Ebola virus from entering cells. Credit: Cydney Scott, Boston University Photography. Robert Davey, professor of microbiology at Boston University School of Medicine and researcher at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), in collaboration with researchers at Nagasaki University, […]Continue Reading ...
It was recently reported that the number of Ebola cases in the Democratic Republic of Congo has surpassed 1,000, making it the second-worst outbreak in history after the 2014 outbreak in West Africa in which 29,000 people were infected and more than 11,000 died. This latest milestone is a stark reminder of the urgent need […]Continue Reading ...
A research team from Tübingen and Göttingen has described in the renowned journal Cell Reports a new mechanism how the Ebola virus escapes the immune system. The virus causes infected cells to release decoys that inactivate neutralizing antibodies and prevent immune cells from releasing important messenger molecules. These findings could lead to the development of […]Continue Reading ...
A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children’s Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Cincinnati Children’s is one of nine […]Continue Reading ...
The government of Liberia, in partnership with the Center for Infection and Immunity (CII) at the Columbia University Mailman School of Public Health and EcoHealth Alliance, announced the discovery of Ebola virus in a bat in Liberia. This is the first finding of Zaire ebolavirus in a bat in West Africa, adding to other evidence […]Continue Reading ...
There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. The findings are now available in Cell Host & Microbe. Dr. Thomas Geisbert, a world-renowned Ebola researcher at The University of Texas Medical Branch, said that previous therapeutics typically were […]Continue Reading ...
Ebola virus particles (red) on a larger cell. Credit: NIAID No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes and UC San Francisco may finally change that. Scientists identified […]Continue Reading ...
A female baby was diagnosed with the deadly Ebola when she was only six days old. According to the health officials in the Democratic Republic of the Congo (DRC), she seemed to have miraculously recovered from the viral infection. Ebola virus seen under a microscope. Image Credit: Studio_3321 / Shutterstock The baby named Benedicte was […]Continue Reading ...
- Smart assistants could help combat opioid crisis
- Diagnostic stewardship strategy reduces inappropriate testing
- Three-antibiotic cocktail eradicates ‘persister’ Lyme bacteria in mouse model
- Study investigates how early blindness shapes sound processing
- Outcomes Worse for Cancer Patients Seen at Noncancer EDs
- Link found between temperament of high-risk infants and obesity
- Al Letson explores ties between journalists and doctors at Medicine and the Muse symposium
- New mobile phone game can detect people at risk of Alzheimer’s
- Exercise activates brain circuits associated with memory in older adults
- Veggies, Fruits and Grains Keep Your Heart Pumping
- Healthy meal kits can boost children’s long-term health
- Designing an inexpensive surgical headlight: A Q&A with a Stanford surgeon
- States Weigh Banning A Widely Used Pesticide Even Though EPA Won’t
- Integrator complex proteins are crucial for healthy brain development in fruit flies, study finds
- Device converts brain signals into speech, offering hope for patients
- Measles vaccination rates are a ‘public health time bomb’
- Maths made easier for scientists students who shun the subject wins award
- Researchers decode how cancer drug works in brains of Parkinson’s disease patients
- Smarter Brain Cancer Trial Comes to Columbia
- Researchers Seek Sage Advice Of Elders On Aging Issues